• Home
  • News & IR
  • News
Digital Therapeutics
디지털헬스산업, 코로나19로 급부상…규제개선 필수'
2021-08-02
Digital Therapeutics
디지털치료제, 비만•당뇨로 범위 확장…
2021-07-28
Bio Vaccine
한미약품그룹-레고켐바이오, 이중항체 ADC 항암신약 공동개발
2021-07-23
Digital Therapeutics
‘디지털 치료제’ 시장 급성장 전망...펀드 시장도 움직인다
2021-07-14
Bio Vaccine
Hanmi Science Aims to Grow into Global Vaccine Hub Company
2021-07-06
K-HUB
mRNA 준비된 한미약품, WHO '백신허브' 선정 노린다
2021-07-06
Bio Vaccine
NIH visits Hanmi Fine Chemical to verify mRNA technology
2021-07-01
Bio Vaccine
한미정밀화학 "국립보건연구원이 방문해 mRNA원료기술 현장검증"
2021-07-01
K-HUB
Team Korea formed to develop mRNA vaccine for complete self-sufficiency by next yr
2021-06-30
  1.   
  2. 37
  3. 38
  4. 39
  5. 40
  6. 41
  7. 42
  8. 43
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.